Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Leo Kusuda"'
Autor:
Judd W. Moul, Douglas W. Soderdahl, Leo Kusuda, David G. McLeod, Wade J. Sexton, Leon Sun, Andrew Chung, Javier Hernandez, Timothy R. Donahue, Hongyu Wu, Keith J. O’Reilly, Christopher L. Amling
Publikováno v:
Journal of Urology. 171:1141-1147
Hormonal therapy (HT) is the current mainstay of systemic treatment for prostate specific antigen (PSA) only recurrence (PSAR), however, there is virtually no published literature comparing HT to observation in the clinical setting. The goal of this
Autor:
Leon Sun, David G. McLeod, John P. Foley, Leo Kusuda, Douglas W. Soderdahl, Judd W. Moul, Wade J. Sexton, Timothy R. Donahue, Christopher L. Amling, Hongyan Wu, Andrew Chung, Hongyu Wu, Raymond S. Lance
Publikováno v:
Journal of Urology. 171:1111-1116
Watchful waiting remains an important treatment option for some patients with localized prostate cancer. We defined the demographic, clinical and outcome features of men selecting watchful waiting as an initial treatment strategy, and determined fact
Autor:
Christopher L. Amling, Timothy R. Donahue, Wade J. Sexton, David G. McLeod, Douglas W. Soderdahl, Judd W. Moul, Leon Sun, Andrew Chung, Raymond S. Lance, Hongyu Wu, John P. Foley, Leo Kusuda
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 21:447-455
Radical Prostatectomy (RP) has been traditionally associated with significant operative blood loss and high risk of transfusion. However, over the last few years, centers of excellence have reported less bleeding and transfusion. To verify and docume
Autor:
Judd W. Moul, Edmond L. Paquette, Kevin J Gancarczyk, David G. McLeod, Leo Kusuda, Raymond S. Lance, Douglas W. Soderdahl, Dalton Baldwin, Christopher J. Kane, Hongyu Wu, Jay T. Bishoff, Linda Xu, John P. Foley, Judy Herring, Leon Sun
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 6:203-209
The Center for Prostate Disease Research (CPDR) database was developed to standardize the clinical procedures for patients with carcinoma of the prostate (CaP), and support retrospective and prospective studies on CaP within the military health care
Autor:
Douglas W. Soderdahl, Robert H. Riffenburgh, Judd W. Moul, Leon Sun, John P. Foley, Wade J. Sexton, Leo Kusuda, Andrew Chung, David G. McLeod, Raymond S. Lance, Christopher L. Amling, Timothy F. Donahue
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 22(3)
Purpose To determine if obesity is associated with higher prostate specific antigen recurrence rates after radical prostatectomy (RP), and to explore racial differences in body mass index (BMI) as a potential explanation for the disparity in outcome
Autor:
Leon Sun, Corey A. Carter, Timothy R. Donahue, S. Jackmaan, Hongyan Wu, Douglas W. Soderdahl, John P. Foley, Leo Kusuda, Andrew Chung, Raymond S. Lance, David G. McLeod, Wade J. Sexton, G. Amling, Judd W. Moul
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 21(21)
Purpose: Watchful waiting (WW) is an acceptable strategy for managing prostate cancer (PC) in older men. Prostate-specific antigen (PSA) testing has resulted in a stage migration, with diagnoses made in younger men. An analysis of the Department of D
Autor:
John P. Foley, Andrew Chung, Wade J. Sexton, Judd W. Moul, Leo Kusuda, Timothy R. Donahue, Leon Sun, Douglas W. Soderdahl, Christopher L. Amling, David G. McLeod, Raymond S. Lance, Jason C. Massengill, Hongyu Wu
Publikováno v:
The Journal of urology. 169(5)
In the last decade numerous groups have shown that low levels of pretreatment serum total testosterone consistently predict more aggressive disease, worse prognosis and worse treatment response in patients with metastatic prostate cancer. Prior studi
Autor:
John P. Foley, Dalton Baldwin, Hongyu Wu, Jay T. Bishoff, Kevin J Gancarczyk, David G. McLeod, Christopher J. Kane, Leo Kusuda, Judd W. Moul, Judy Herring, Raymond S. Lance, Douglas W. Soderdahl
Publikováno v:
Urology. 61(3)
Objectives To develop probability nomograms to predict pathologic outcome at the time of radical prostatectomy (RP) on the basis of established prognostic factors and prostate biopsy quantitative histology. Methods Using information from the database
Autor:
Peter A S, Johnstone, Robert H, Riffenburgh, Judd W, Moul, Leon, Sun, Hongyu, Wu, David G, McLeod, Christopher J, Kane, Douglas D, Martin, Leo, Kusuda, Raymond, Lance, Robert, Douglas, Timothy, Donahue, Michael G, Beat, John, Foley, Andrew, Chung, Douglas, Soderdahl, Jason, Do, Christopher L, Amling
Publikováno v:
International journal of radiation oncology, biology, physics. 55(4)
It has traditionally been a common perception that young age is a negative prognostic factor in prostate cancer (CaP). Furthermore, many urologists believe that younger patients are better suited to surgery rather than radiotherapy (RT) because of th
Autor:
Douglas W. Soderdahl, Peter A.S. Johnstone, David G. McLeod, Raymond S. Lance, Timothy R. Donahue, Hongyu Wu, Judd W. Moul, Michael G. Beat, Christopher L. Amling, John F. Foley, Dalton Baldwin, Douglas Martin, Christopher J. Kane, Robert F. Douglas, Leon Sun, Jason Do, Leo Kusuda
Publikováno v:
Radiology. 225(2)
To report on the first collaboration of the Department of Defense Center for Prostate Disease Research concerned with the relationship between African American race and biochemical disease-free outcomes after definitive radiation therapy.Information